FDA Warning Letter — San Diego Compounding Pharmacy
The FDA took a Warning Letter action against San Diego Compounding Pharmacy on September 25, 2017 (San Diego, CA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- San Diego Compounding Pharmacy
- Date
- September 25, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- San Diego, CA (United States)